142 related articles for article (PubMed ID: 10232889)
1. Divergent illicit drug policies in Europe.
Ann Oncol; 1998 Dec; 9(12):1257. PubMed ID: 10232889
[No Abstract] [Full Text] [Related]
2. Drug problems in Amsterdam.
Scheele W
Practitioner; 1989 Nov; 233(1478):1484-5. PubMed ID: 2616528
[TBL] [Abstract][Full Text] [Related]
3. Heroin prescription in Europe: heroin treatment is a pragmatic way of reducing the risks associated with addiction.
Prescrire Int; 2003 Dec; 12(68):235-6. PubMed ID: 14986702
[No Abstract] [Full Text] [Related]
4. Heroin-assisted treatment in Switzerland: a case study in policy change.
Uchtenhagen A
Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519
[TBL] [Abstract][Full Text] [Related]
5. Combined effects of law enforcement and substitution treatment on heroin mortality.
Nordt C; Stohler R
Drug Alcohol Rev; 2010 Sep; 29(5):540-5. PubMed ID: 20887578
[TBL] [Abstract][Full Text] [Related]
6. Should the controlled provision of heroin be a treatment option? Australian feasibility considerations.
Bammer G
Addiction; 1993 Apr; 88(4):467-75. PubMed ID: 8485424
[TBL] [Abstract][Full Text] [Related]
7. [Methadone treatment of heroin addiction in family practice. Risks and guidelines].
Hartmann H; Uchtenhagen A; Fuchs W; Pasi A
Schweiz Rundsch Med Prax; 1984 Mar; 73(10):299-304. PubMed ID: 6709990
[No Abstract] [Full Text] [Related]
8. The effectiveness of the medical prescription of heroin studied by randomized trials in The Netherlands, watched suspiciously by parliament and neighborhoods.
Spruit IP
Subst Use Misuse; 2002 Mar; 37(4):555-63. PubMed ID: 12064437
[No Abstract] [Full Text] [Related]
9. Recent developments in maintenance prescribing and monitoring in the United Kingdom.
Brewer C
Bull N Y Acad Med; 1995; 72(2):359-70. PubMed ID: 10101376
[TBL] [Abstract][Full Text] [Related]
10. Prescribing heroin: nothing to fear but fear itself?
Wodak A
Med J Aust; 1998 Jun; 168(12):590-1. PubMed ID: 9673617
[No Abstract] [Full Text] [Related]
11. Legal and ethical issues in heroin diagnosis, treatment, and research.
Loue S; Ioan B
J Leg Med; 2007; 28(2):193-221. PubMed ID: 17558793
[No Abstract] [Full Text] [Related]
12. Heroin prescription and history.
Berridge V
N Engl J Med; 2009 Aug; 361(8):820-1. PubMed ID: 19692694
[No Abstract] [Full Text] [Related]
13. Methadone maintenance treatment of heroin abuse in China.
Lu L; Zhao D; Bao YP; Shi J
Am J Drug Alcohol Abuse; 2008; 34(2):127-31. PubMed ID: 18293229
[No Abstract] [Full Text] [Related]
14. The ACT heroin trial proposal: an overview. Australian Capital Territory.
Bammer G; Douglas RM
Med J Aust; 1996 Jun; 164(11):690-2. PubMed ID: 8657034
[No Abstract] [Full Text] [Related]
15. Work and the journey to recovery: exploring the implications of welfare reform for methadone maintenance clients.
Monaghan M; Wincup E
Int J Drug Policy; 2013 Nov; 24(6):e81-6. PubMed ID: 24360401
[TBL] [Abstract][Full Text] [Related]
16. [New drug policies: the Geneva example].
Mino A
Psychiatr Enfant; 1994; 37(2):577-99. PubMed ID: 7878141
[TBL] [Abstract][Full Text] [Related]
17. Prescribing heroin.
Caltrider W
Science; 1999 Jul; 285(5427):532-3; author reply 533. PubMed ID: 10447484
[No Abstract] [Full Text] [Related]
18. NIDA's Medication Development Program--1989.
Schuster CR; Snyder M
NIDA Res Monogr; 1989; 95():64-73. PubMed ID: 2641056
[No Abstract] [Full Text] [Related]
19. The current New York City heroin scene.
Spunt B
Subst Use Misuse; 2003 Aug; 38(10):1539-49. PubMed ID: 14509550
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of heroin-assisted treatment in Germany.
Verthein U; Bonorden-Kleij K; Degkwitz P; Dilg C; Köhler WK; Passie T; Soyka M; Tanger S; Vogel M; Haasen C
Addiction; 2008 Jun; 103(6):960-6; discussion 967-8. PubMed ID: 18422829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
